(Q37974467)

26 August 2017

title

IBD in 2011: Advances in IBD management--towards a tailored approach (English)

1 reference

26 August 2017

author name string

Guillaume P Pineton de Chambrun

series ordinal

1

1 reference

26 August 2017

William J Sandborn

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

10 January 2012

1 reference

Nature Reviews Gastroenterology & Hepatology

26 August 2017

published in

1 reference

26 August 2017

volume

9

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

70-72

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2011.248

26 August 2017

exact match

0 references

cites work

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.248

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.248

Clinical implications of mucosal healing for the management of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.248

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.248

Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.248

Infliximab, azathioprine, or combination therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.248

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.248

Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.248

Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.248

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.248

10.1038/NRGASTRO.2011.248

31 March 2020

Identifiers

DOI

1 reference

26 August 2017

1 reference